cycloheximide has been researched along with bay 11-7085 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Benoit, V; Bours, V; Chariot, A; Delacroix, L; Deregowski, V; Jacobs, N; Merville, MP | 1 |
2 other study(ies) available for cycloheximide and bay 11-7085
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expression.
Topics: Adenocarcinoma; Anti-Infective Agents; Apoptosis; Binding Sites; Breast Neoplasms; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cycloheximide; Enzyme Activation; Humans; Intracellular Signaling Peptides and Proteins; NF-kappa B; Nitriles; Receptor, ErbB-2; Stimulation, Chemical; Sulfones; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2004 |